Study ID: TVP-1012-A001-201
Study Title
- Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
Teva Identifier
- TVP-1012-A001-201
ClinicalTrials.gov Identifier
- NCT00104273
Study Status
- Completed
Trial Condition(s)
- Dementia | Alzheimer's Disease
Interventions
- Drug: Rasagiline
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 45 Years to 90 Years
Trial Duration
- 08/01/2004 - 01/00/1900
Phase
- Phase 2
Study Type
Interventional
